T, W., M, Z., M, Y., H, K., J, S., TL, H., . . . Z, X. (2026). Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma. Scientific reports, 16(1), . https://doi.org/10.1038/s41598-026-48331-7
Chicago Style (17th ed.) CitationT, Worlikar, Zhang M, Yu M, Kim H, Shi J, Hall TL, Mendiratta-Lala M, Cho CS, and Xu Z. "Histotripsy Dose Impacts Tumor Cellular Damage and Treatment Outcomes in a Preclinical Model of Hepatocellular Carcinoma." Scientific Reports 16, no. 1 (2026). https://doi.org/10.1038/s41598-026-48331-7.
MLA (9th ed.) CitationT, Worlikar, et al. "Histotripsy Dose Impacts Tumor Cellular Damage and Treatment Outcomes in a Preclinical Model of Hepatocellular Carcinoma." Scientific Reports, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41598-026-48331-7.